BriSTAR Immunotech
PrivateLast Round
Series C
Jul 6, 2026
Total Funding Raised
$65.5M
Company Overview
BriSTAR Immunotech is a clinical-stage biotechnology company that develops engineered T-cell immunotherapy products for cancer and autoimmune diseases using its proprietary STAR-T and enTCR-T technology platforms.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BriSTAR Immunotech Comparables
Compare BriSTAR Immunotech with similar companies based on industry and business-model similarity.
BriSTAR Immunotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jul 6, 2026 | ||||
| Series B Extension | Jul 18, 2022 | ||||
| Series B | Oct 11, 2021 | ||||
| Series A Extension | Jan 1, 2020 |
BriSTAR Immunotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Beijing Chang Development | Series B |
| Loyal Valley Capital | Series C |
| Shenzhen Sangel Venture Capital | Series B |
| Highlight Capital | Series B |
| Daoyuan Capital | Series B |
| Qifu Capital | Series A, Angel, Pre Seed |
| Hankang Capital | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 18, 2022
Completed a Series B Extension round of funding.
- Oct 11, 2021
$31M round led by 华创资本
BriSTAR Immunotech Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about BriSTAR Immunotech's valuation, stock price, and market status.